(Q31120016)

29 June 2017

A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro (English)

1 reference

29 June 2017

Yasuhiro Nakagami

1

1 reference

29 June 2017

Satoko Nishimura

2

1 reference

29 June 2017

Takako Murasugi

3

1 reference

29 June 2017

Takekazu Kubo

4

1 reference

29 June 2017

Isao Kaneko

5

1 reference

29 June 2017

Masaki Meguro

6

1 reference

29 June 2017

Shinji Marumoto

7

1 reference

29 June 2017

Hiroshi Kogen

8

1 reference

29 June 2017

Kazuo Koyama

9

1 reference

29 June 2017

Tomiichiro Oda

10

1 reference

29 June 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

European Journal of Pharmacology

29 June 2017

1 reference

29 June 2017

457

1 reference

29 June 2017

11-17

1 reference

29 June 2017

1

1 reference

Dendritic changes in Alzheimer's disease and factors that may underlie these changes

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Design and testing of inhibitors of fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Treatment of Alzheimer's disease: rationale and strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Screening for pharmacologic inhibitors of amyloid fibril formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

LTP mechanisms: from silence to four-lane traffic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

A novel beta-sheet breaker, RS-0406, reverses amyloid beta-induced cytotoxicity and impairment of long-term potentiation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Alzheimer's disease: genes, proteins, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902657-2

10.1016/S0014-2999(02)02657-2

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference